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Percutaneous closure of cardiac catheterization
sites has been advocated to achieve earlier hemosta-
sis, improve patient comfort, promote early ambula-
tion, decrease the length of stay, and prevent post-
procedure bleeding.1-3 We reviewed our recent
experience with two products, the Perclose and the
Angio-Seal femoral artery closure devices. The
Perclose (Perclose Inc, Redwood, Calif) is a device
that places a nonabsorbable braided polyester suture
on both sides of the femoral artery defect on
removal of the femoral catheter. The arteriotomy is
then closed by tying the suture. The Angio-Seal
(Sherwood Davis and Geck, St Louis, Mo) is a clo-
sure device that uses an absorbable intraluminal
anchor and an extraluminal collagen sponge to be
used as a tamponade for the arteriotomy. An
absorbable braided suture draws the anchor and col-
lagen together to form a seal.
In approximately 450 patients in whom the
devices were used after a cardiac catheterization,
there were three complications due to infection.
Two of the patients had infected pseudoaneurysms,
and the third patient had a complex groin infection
requiring extensive debridement. Before this experi-
ence, there were no identified infectious complica-
tions of femoral arterial catheterization at this insti-
tution. The infections in these patients appear to be
multifactorial in etiology, but clearly associated with
the foreign body.
CASE REPORTS
Case 1. A 54-year-old woman with a past history of
hypertension, type 2 diabetes mellitus, and peripheral vas-
cular disease was seen with symptoms suggestive of unsta-
ble angina, and she underwent a diagnostic cardiac
catheterization from a right femoral approach. The coro-
nary angiogram revealed normal coronary arteries, and
her femoral artery was closed with the Perclose device
after limited femoral arteriography indicated an adequate
lumen for deployment. She was discharged on the day of
the catheterization and had staphylococcal sepsis 16 days
later. She was febrile and had a white blood cell count of
32 ×103/mm3. A tender, pulsatile mass with surrounding
erythema was present in her right groin. She was taken to
the operating room for urgent exploration of her femoral
artery. Proximal control of the external iliac artery was
obtained in the retroperitoneum through an oblique flank
incision, and a vertical incision was then made over the
femoral artery in the groin. Blood and purulent material
were aspirated, and control of the superficial and deep
femoral arteries was obtained. There was extensive necro-
sis of the anterior wall of the common femoral artery. This
arterial injury was repaired with patch angioplasty using
the greater saphenous vein from the contralateral lower
extremity. Her groin wound was closed over a suction
drain, and the other wounds were closed pri-
marily. Intraoperative cultures grew methicillin-sensitive
Staphylococcus aureus, as did the preoperative blood cul-
tures. The patient was treated with cefazolin for a total of
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10 days, and she was discharged home on the ninth post-
operative day.
Case 2. A 55-year-old man with a history of coronary
artery disease, hypertension, and type 1 diabetes mellitus
was seen with stable angina and underwent a diagnostic
cardiac catheterization. He had three-vessel coronary
artery disease. After limited femoral arteriography, the
right femoral artery was closed with the Perclose device.
He was discharged on the day of his catheterization, and he
was scheduled for coronary artery bypass grafting 3 weeks
later. However, 13 days after the catheterization, he went
to the emergency department with complaints of bleeding
and purulent drainage from his right groin. He was afebrile
and had a white blood cell count of 9 ×103/mm3. Duplex
scanning examination of the right groin revealed a
pseudoaneurysm (Figure). He was taken to the operating
room for urgent exploration, and proximal control of the
external iliac artery was obtained in the retroperitoneum
with flank incision. Distal control of the superficial and
deep femoral arteries was obtained through a separate
groin incision. Once the pseudoaneurysm was entered,
blood and purulent material were aspirated. There was
complete necrosis of the common femoral artery, which
necessitated in situ repair with iliofemoral bypass grafting
using the reversed greater saphenous vein obtained from
the ipsilateral ankle. The sartorius muscle was mobilized
and rotated to cover the graft. The flank incision was
closed primarily; however, the groin wound was left open
because of the extensive inflammation and fibrosis of the
surrounding tissue. Intraoperative cultures grew methi-
cillin-sensitive S aureus. The patient was treated with intra-
venous cefazolin for 14 days. The groin incision required
prolonged local wound care but was completely healed at
follow-up on postoperative day 50. The patient was then
cleared for cardiac revascularization surgery.
Case 3. A 63-year-old man with a history of hyperten-
sion, coronary artery disease and type 2 diabetes mellitus
underwent a diagnostic cardiac catheterization for stable
angina. His femoral artery was closed with the Angio-Seal
device after limited femoral arteriography demonstrated an
adequate lumen. He was discharged later on the day of the
catheterization, and 12 days later he complained of pain in
the groin through which the catheterization was per-
formed. He was afebrile and had a white blood cell count
of 13 ×103/mm3. He had erythema and swelling at the
catheterization site. A duplex scanning examination of the
groin revealed a 3-cm fluid collection anterior to the
femoral artery, but there was no obvious pseudoaneurysm.
He was taken to the operating room for exploration of the
right groin. A large amount of clotted blood and purulent
debris surrounded the common femoral artery; however,
the artery itself was intact. The suture from the closure
device was contained within the infected hematoma. After
extensive soft tissue debridement and pulsatile lavage, the
wound was packed open to heal secondarily. Intraoperative
cultures grew methicillin-sensitive S aureus. The patient
remained hospitalized on the cardiology service, and he
was treated with intravenous vancomycin and local wound
care. He was discharged on the ninth postoperative day to
continue local wound care at home.
DISCUSSION
Percutaneous femoral artery closure devices
have been developed to allow for early ambulation,
to decrease the length of stay, and to prevent
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Duplex scanning examination of an infected femoral
pseudoaneurysm. Color photograph (top) shows the
femoral artery (FA) with a pseudoaneurysm extending
anteriorly. The pseudoaneurysm cavity is obliterated with
purulent debris. The neck (N) of the pseudoaneurysm is
seen extending from the common femoral artery. The
arrow in the lower photograph indicates the pseudo-
aneurysm capsule.
bleeding after femoral cannulation procedures.
They are proposed to improve both patient com-
fort and catheterization laboratory productivity
when compared with traditional manual or
mechanical pressure to achieve hemostasis after
sheath removal.2,4 In our institution, the Angio-
Seal and the Perclose devices have been used in
approximately 450 patients undergoing diagnostic
and therapeutic cardiac catheterization. The three
cases reported here represent our initial experience
with infectious complications after femoral artery
instrumentation. These complications have each
necessitated urgent surgical intervention, pro-
longed hospitalizations, and extended recovery
periods. Two patients had large open wounds that
required frequent dressing changes to achieve clo-
sure by secondary intention. In one case, coronary
artery bypass surgery was delayed for 2 months
until the wounds healed.
Several similarities among these cases deserve
mention. Each patient underwent a diagnostic study
using a 6-French catheter. Although all of the
patients were taking aspirin, none received peripro-
cedural anticoagulation. As a consequence of under-
lying diabetes, all three of these patients were
immunocompromised to some degree. The
pathogen identified in all three patients was a com-
mon skin organism, S aureus; however, according to
the standard practice, none of these patients received
antibiotics before the catheterization procedure. In
addition to these similarities in patient characteris-
tics, both of these closure devices leave a suture that
extends from the femoral artery to the skin, and this
suture was recovered at surgery in all cases. Because
the suture was amputated at skin level at the time of
placement, several centimeters of foreign material
remained in each wound. From the analysis of these
cases, we postulated that the long sutures provided
an access tract for skin flora to reach the deep tissues,
and the combination of diabetes and foreign body
contributed to the virulence of the local infection.
A cardiac catheterization is one of the most
common medical procedures performed in the
United States, with approximately 1 million proce-
dures performed annually.5 In the current era of
aggressive periprocedural anticoagulation, femoral
artery closure devices are especially attractive for
potentially decreasing the time to achieve hemosta-
sis and ambulation and for increasing the produc-
tivity of catheterization laboratories.2,6 Early
studies of these and other closure devices have
demonstrated their clinical efficacy in achieving
hemostasis and decreasing the incidence of minor
bleeding complications.7-9 In a study of 1030 con-
secutive patients who had cardiac catheterization in
whom the Perclose was deployed, successful clo-
sure was reported in approximately 90% of cases.10
This has been demonstrated even in patients receiv-
ing heparin anticoagulation and antiplatelet thera-
py with abciximab (ReoPro; Eli Lilly, Indianapolis,
Ind).6 In addition, a recent study in which the
Angio-Seal device was used has shown that patients
can safely ambulate within an hour after femoral
sheath removal.2 Despite such favorable data, none
of the studied closure devices have been shown to
decrease the rate of major vascular complications
associated with femoral catheterization including
pseudoaneurysm, arteriovenous fistula, dissection,
or acute thrombosis.7 Although in some cases the
time to achieve hemostasis appears to be shortened
by the use of these devices, the success rates of
achieving hemostasis have been slightly less than
that demonstrated by the use of mechanical pres-
sure devices alone.6
The widespread implementation of any new
technology must proceed only after careful cost-
benefit analysis. In the case of femoral artery closure
devices, the additional femoral arteriography must
be included with the unit cost of the device itself.
The bleeding, mechanical, and the added infectious
risks of deploying the device must then be compared
with the expected benefit of earlier discharge from
the outpatient unit and increased patient turnover.
These logistical benefits may be abrogated by the
arterial damage and wound complications associated
with infections even if only a few patients are affect-
ed. In angioplasty and atherectomy cases, especially
those in which aggressive antiplatelet therapy is
used, the potential benefits of closure devices are
even less tangible because early sheath removal and
ambulation are not of practical concern in these
patients.
These are the first reported cases of infected
pseudoaneurysm after percutaneous femoral artery
closure following cardiac catheterization. A single
case report of sepsis and wound infection associated
with one of the closure devices has recently been
published.11 Although infectious complications
represent a small fraction of our overall experience
with these devices, they must be added to the list of
potential adverse events associated with their use.
We have treated only one other complication, a
femoral occlusion caused by the Angio-Seal; how-
ever, the true incidence of complications in our
series is unknown because minor infections or
mechanical complications may not have prompted
JOURNAL OF VASCULAR SURGERY
Volume 32, Number 1 Pipkin et al 207
surgical consultation. Because the use of these
devices remains in its relative infancy, it is uncertain
what the infectious complication rate will ultimate-
ly be. Infectious complications after femoral artery
cannulation can lead to significant morbidity, neces-
sitating expensive inpatient treatment and pro-
longed outpatient therapy.
As a result of this experience, patients in whom
the use of these devices is considered now receive
prophylactic antibiotics, as would any patient under-
going implantation of a vascular device. Prophylactic
antibiotics have been advocated by the manufactur-
ers of both devices in immunocompromised patients;
however, it is not known if the use of periprocedural
antibiotics will decrease the incidence of infectious
complications. Further prospective studies will be
needed to evaluate whether this will be of benefit. In
addition, as new data come to light concerning the
complications associated with percutaneous femoral
artery closure devices, careful consideration is war-
ranted before these devices are advocated for routine
use after cardiac catheterization.
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